# Markus Ketteler

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/markus-ketteler/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,188 |
| Field | Parathyroid Disorders and Treatments |
| h-index | 72 |
| i10-index | 192 |
| Last Known Institution | Robert Bosch Hospital |
| OpenAlex ID | https://openalex.org/A5046643853 |
| ORCID iD | https://orcid.org/0000-0002-7214-1895 |
| Works | 445 |

## Researcher papers

- [IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly](https://scholariq.org/papers/il-10-il-6-and-tnf-central-factors-in-the-altered-cytokine-network-of-uremia-the/)
- [Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study](https://scholariq.org/papers/association-of-low-fetuin-a-ahsg-concentrations-in-serum-with-cardiovascular/)
- [The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification](https://scholariq.org/papers/the-serum-protein-2-heremans-schmid-glycoprotein-fetuin-a-is-a-systemically/)
- [Vascular calcification in chronic kidney disease](https://scholariq.org/papers/vascular-calcification-in-chronic-kidney-disease/)
- [Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism](https://scholariq.org/papers/effect-of-etelcalcetide-vs-cinacalcet-on-serum-parathyroid-hormone-in-patients/)
- [Effect of Vitamin K2 Supplementation on Functional Vitamin K Deficiency in Hemodialysis Patients: A Randomized Trial](https://scholariq.org/papers/effect-of-vitamin-k2-supplementation-on-functional-vitamin-k-deficiency-in/)
- [Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference](https://scholariq.org/papers/controversies-in-optimal-anemia-management-conclusions-from-a-kidney-disease/)
- [Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study](https://scholariq.org/papers/improvement-of-mineral-and-bone-metabolism-markers-is-associated-with-better/)
- [A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients](https://scholariq.org/papers/a-phase-iii-study-of-the-efficacy-and-safety-of-a-novel-iron-based-phosphate/)
- [Development of an International Standard Set of Value-Based Outcome Measures for Patients With Chronic Kidney Disease: A Report of the International Consortium for Health Outcomes Measurement (ICHOM) CKD Working Group](https://scholariq.org/papers/development-of-an-international-standard-set-of-value-based-outcome-measures-for/)

## Researcher topics

- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Magnesium in Health and Disease](https://scholariq.org/topics/magnesium-in-health-and-disease/)
- [Vitamin D Research Studies](https://scholariq.org/topics/vitamin-d-research-studies-2/)
- [Thyroid and Parathyroid Surgery](https://scholariq.org/topics/thyroid-and-parathyroid-surgery-2/)

## Researcher university

- [Robert Bosch Hospital](https://scholariq.org/institutions/robert-bosch-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.